La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
Oncology Institute Résultats passés
Passé contrôle des critères 0/6
Oncology Institute's earnings have been declining at an average annual rate of -67%, while the Healthcare industry saw earnings growing at 7.1% annually. Revenues have been growing at an average rate of 22.4% per year.
Informations clés
-67.0%
Taux de croissance des bénéfices
-67.7%
Taux de croissance du BPA
| Healthcare Croissance de l'industrie | 8.5% |
| Taux de croissance des recettes | 22.4% |
| Rendement des fonds propres | -245.0% |
| Marge nette | -16.2% |
| Dernière mise à jour des bénéfices | 30 Jun 2024 |
Mises à jour récentes des performances passées
Recent updates
A Piece Of The Puzzle Missing From The Oncology Institute, Inc.'s (NASDAQ:TOI) 28% Share Price Climb
Jul 19
The Oncology Institute, Inc. (NASDAQ:TOI) Stock's 29% Dive Might Signal An Opportunity But It Requires Some Scrutiny
May 05Not Many Are Piling Into The Oncology Institute, Inc. (NASDAQ:TOI) Stock Yet As It Plummets 28%
Mar 21Is Oncology Institute (NASDAQ:TOI) A Risky Investment?
Mar 05The Oncology Institute, Inc. (NASDAQ:TOI) Stock Rockets 49% But Many Are Still Ignoring The Company
Nov 10The Oncology Institute swings to Q2 GAAP loss per share from year-ago profit
Aug 09Shareholders Shouldn’t Be Too Comfortable With Oncology Institute's (NASDAQ:TOI) Strong Earnings
May 18Companies Like Oncology Institute (NASDAQ:TOI) Are In A Position To Invest In Growth
Mar 16Ventilation des recettes et des dépenses
Comment Oncology Institute gagne et dépense de l'argent. Sur la base des derniers bénéfices déclarés, sur une base LTM.
Historique des gains et des recettes
| Date | Recettes | Les revenus | Dépenses G+A | Dépenses de R&D |
|---|---|---|---|---|
| 30 Jun 24 | 361 | -59 | 113 | 0 |
| 31 Mar 24 | 343 | -60 | 113 | 0 |
| 31 Dec 23 | 324 | -68 | 114 | 0 |
| 30 Sep 23 | 310 | -61 | 113 | 0 |
| 30 Jun 23 | 293 | -50 | 120 | 0 |
| 31 Mar 23 | 274 | -40 | 120 | 0 |
| 31 Dec 22 | 252 | 0 | 120 | 0 |
| 30 Sep 22 | 233 | -1 | 137 | 0 |
| 30 Jun 22 | 221 | -2 | 118 | 0 |
| 31 Mar 22 | 210 | 6 | 100 | 0 |
| 31 Dec 21 | 203 | -11 | 83 | 0 |
| 30 Sep 21 | 200 | -6 | 50 | 0 |
| 30 Jun 21 | 195 | -3 | 46 | 0 |
| 31 Mar 21 | 192 | -5 | 44 | 0 |
| 31 Dec 20 | 188 | -14 | 42 | 0 |
| 31 Dec 19 | 155 | -4 | 30 | 0 |
| 31 Dec 18 | 113 | -2 | 17 | 0 |
Des revenus de qualité: TOI is currently unprofitable.
Augmentation de la marge bénéficiaire: TOI is currently unprofitable.
Analyse des flux de trésorerie disponibles par rapport aux bénéfices
Analyse de la croissance passée des bénéfices
Tendance des revenus: TOI is unprofitable, and losses have increased over the past 5 years at a rate of 67% per year.
Accélération de la croissance: Unable to compare TOI's earnings growth over the past year to its 5-year average as it is currently unprofitable
Bénéfices par rapport au secteur d'activité: TOI is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (6%).
Rendement des fonds propres
ROE élevé: TOI has a negative Return on Equity (-244.95%), as it is currently unprofitable.